cromolyn sodium has been researched along with Alzheimer Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, NH; Choi, S; Choi, SB; Elmaleh, DR; Hwang, E; Jang, BC; Kim, A; Kim, CH; Kim, HC; Kwon, S; Lakshmana Perumal, N; Lee, JH; Song, H; Yang, SH; Yang, WS | 1 |
| Brugarolas, P; Dhaynaut, M; Elmaleh, DR; Fakhri, GE; Griciuc, A; Guehl, NJ; Moon, SH; Normandin, MD; Quinti, L; Shoup, TM; Tanzi, RE; Walsh, LV | 1 |
| Albertini, C; Bartolini, M; Bolognesi, ML; Grifoni, D; Monti, B; Naldi, M; Petralla, S; Strocchi, S | 1 |
| Ashton-Rickardt, PG; Downey, MA; Elmaleh, DR; Monteagudo, A; Wang, YJ | 1 |
| Elmaleh, DR; Forte, AM; Griciuc, A; Hudry, E; Quinti, L; Ran, C; Shen, X; Tanzi, RE; Wan, Y; Ward, J; Zhang, C | 1 |
| Cho, H; Elmaleh, DR; Hori, Y; Hudry, E; Hyman, BT; Irimia, D; Shoup, TM; Takahashi, K; Takeda, S; Wegmann, S | 1 |
6 other study(ies) available for cromolyn sodium and Alzheimer Disease
| Article | Year |
|---|---|
The Derivatives of Cromolyn Ameliorate the Abnormal Misfolding of Amyloid Proteins and Neuroinflammation in the Neural Cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidogenic Proteins; Cromolyn Sodium; Humans; Inflammation; Microglia; Mitogen-Activated Protein Kinases; Neuroinflammatory Diseases; NF-kappa B | 2023 |
Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cell Line; Cells, Cultured; Cromolyn Sodium; Macaca mulatta; Mice; Microglia; Neuroprotective Agents; Peptide Fragments; Phagocytosis | 2021 |
From Combinations to Single-Molecule Polypharmacology-Cromolyn-Ibuprofen Conjugates for Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Cell Survival; Cromolyn Sodium; Drosophila; Drug Design; Endocytosis; Ibuprofen; Immunomodulation; Mice; Microglia; Neurons; Neuroprotective Agents; Neurotoxins; Polypharmacology; Protein Aggregates; Rats, Wistar | 2021 |
Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3).
Topics: Alzheimer Disease; Cromolyn Sodium; Cytokines; Inflammation; Microglia | 2021 |
Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Asthmatic Agents; Brain; Cromolyn Sodium; Disease Models, Animal; Drug Combinations; Drug Repositioning; Gene Expression; Humans; Ibuprofen; Male; Mice; Mice, Transgenic; Microglia; Neurons; Neuroprotective Agents; Peptide Fragments; Phagocytosis; Transgenes | 2018 |
A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cells, Cultured; Cromolyn Sodium; Disease Models, Animal; Drug Approval; Flavonoids; Flavonols; Humans; Mice; Mice, Transgenic; Microglia; Microscopy, Electron, Transmission; Peptide Fragments; United States; United States Food and Drug Administration | 2015 |